Insulin Resistance: Metabolic Mechanisms and Consequences in the Heart

被引:163
作者
Abel, E. Dale [2 ,3 ]
O'Shea, Karen M. [1 ]
Ramasamy, Ravichandran [1 ]
机构
[1] NYU, Dept Med, Diabet Res Program, Langone Med Ctr, New York, NY 10016 USA
[2] Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT USA
[3] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA
基金
美国国家卫生研究院;
关键词
energy metabolism; fatty acids; heart disease; insulin resistance; metabolism; FATTY-ACID OXIDATION; MYOCARDIAL SUBSTRATE METABOLISM; PROTEIN-KINASE-C; ALDOSE REDUCTASE; PPAR-ALPHA; MITOCHONDRIAL DYSFUNCTION; ENDOTHELIAL DYSFUNCTION; DIABETIC CARDIOMYOPATHY; VASCULAR DYSFUNCTION; CERAMIDE SYNTHESIS;
D O I
10.1161/ATVBAHA.111.241984
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin resistance is a characteristic feature of obesity and type 2 diabetes mellitus and impacts the heart in various ways. Impaired insulin-mediated glucose uptake is a uniformly observed characteristic of the heart in these states, although changes in upstream kinase signaling are variable and dependent on the severity and duration of the associated obesity or diabetes mellitus. The understanding of the physiological and pathophysiological role of insulin resistance in the heart is evolving. To maintain its high energy demands, the heart is capable of using many metabolic substrates. Although insulin signaling may directly regulate cardiac metabolism, its main role is likely the regulation of substrate delivery from the periphery to the heart. In addition to promoting glucose uptake, insulin regulates long-chain fatty acid uptake, protein synthesis, and vascular function in the normal cardiovascular system. Recent advances in understanding the role of metabolic, signaling, and inflammatory pathways in obesity have provided opportunities to better understand the pathophysiology of insulin resistance in the heart. This review will summarize our current understanding of metabolic mechanisms for and consequences of insulin resistance in the heart and will discuss potential new areas for investigating novel mechanisms that contribute to insulin resistance in the heart. (Arterioscler Thromb Vasc Biol. 2012;32:2068-2076.)
引用
收藏
页码:2068 / 2076
页数:9
相关论文
共 111 条
  • [1] Cardiac remodeling in obesity
    Abel, E. Dale
    Litwin, Sheldon E.
    Sweeney, Gary
    [J]. PHYSIOLOGICAL REVIEWS, 2008, 88 (02) : 389 - 419
  • [2] Glucose transport in the heart
    Abel, ED
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 201 - 215
  • [3] Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study
    Andersson, C.
    Olesen, J. B.
    Hansen, P. R.
    Weeke, P.
    Norgaard, M. L.
    Jorgensen, C. H.
    Lange, T.
    Abildstrom, S. Z.
    Schramm, T. K.
    Vaag, A.
    Kober, L.
    Torp-Pedersen, C.
    Gislason, G. H.
    [J]. DIABETOLOGIA, 2010, 53 (12) : 2546 - 2553
  • [4] Lipid oversupply, selective insulin resistance, and lipotoxicity: Molecular mechanisms
    Antonio Chavez, Jose
    Summers, Scott A.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2010, 1801 (03): : 252 - 265
  • [5] NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1
    Balteau, Magali
    Tajeddine, Nicolas
    de Meester, Carole
    Ginion, Audrey
    Des Rosiers, Christine
    Brady, Nathan R.
    Sommereyns, Caroline
    Horman, Sandrine
    Vanoverschelde, Jean-Louis
    Gailly, Philippe
    Hue, Louis
    Bertrand, Luc
    Beauloye, Christophe
    [J]. CARDIOVASCULAR RESEARCH, 2011, 92 (02) : 237 - 246
  • [6] Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice
    Battiprolu, Pavan K.
    Hojayev, Berdymammet
    Jiang, Nan
    Wang, Zhao V.
    Luo, Xiang
    Iglewski, Myriam
    Shelton, John M.
    Gerard, Robert D.
    Rothermel, Beverly A.
    Gillette, Thomas G.
    Lavandero, Sergio
    Hill, Joseph A.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (03) : 1109 - 1118
  • [7] Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression
    Belke, DD
    Betuing, S
    Tuttle, MJ
    Graveleau, C
    Young, ME
    Pham, M
    Zhang, DF
    Cooksey, RC
    McClain, DA
    Litwin, SE
    Taegtmeyer, H
    Severson, D
    Kahn, CR
    Abel, ED
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (05) : 629 - 639
  • [8] Heart failure - The frequent, forgotten, and often fatal complication of diabetes
    Bell, DSH
    [J]. DIABETES CARE, 2003, 26 (08) : 2433 - 2441
  • [9] Insulin signalling in the heart
    Bertrand, Luc
    Horman, Sandrine
    Beauloye, Christophe
    Vanoverschelde, Jean-Louis
    [J]. CARDIOVASCULAR RESEARCH, 2008, 79 (02) : 238 - 248
  • [10] BING R J, 1955, Acta Cardiol, V10, P1